Insider Trading & Ownership of Neil Exter

Location
Boston, MA
Summary
The estimated net worth of Neil Exter is at least $1,317,951 dollars as of 24 Sep 2025. Neil Exter is the Director of Revolution Medicines, Inc. and owns shares of Revolution Medicines, Inc. (RVMD) stock worth about $1.32M.
Signature
/s/ Courtney Phillips, as attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Neil Exter and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • Neil Exter has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,317,951.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: Revolution Medicines, Inc. ($1,317,951).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Neil Exter

Insider Transactions Reported by Neil Exter:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .